- Home
- LRHC vs KTTA Comparison
LRHC vs KTTA Comparison
Compare LRHC & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRHC
- KTTA
- Stock Information
- Founded
- LRHC 2004
- KTTA 2020
- Country
- LRHC United States
- KTTA United States
- Employees
- LRHC N/A
- KTTA N/A
- Industry
- LRHC
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- LRHC
- KTTA Health Care
- Exchange
- LRHC Nasdaq
- KTTA Nasdaq
- Market Cap
- LRHC 5.4M
- KTTA 5.1M
- IPO Year
- LRHC 2023
- KTTA 2021
- Fundamental
- Price
- LRHC $7.87
- KTTA $0.74
- Analyst Decision
- LRHC
- KTTA
- Analyst Count
- LRHC 0
- KTTA 0
- Target Price
- LRHC N/A
- KTTA N/A
- AVG Volume (30 Days)
- LRHC 48.1K
- KTTA 201.4K
- Earning Date
- LRHC 08-18-2025
- KTTA 11-12-2025
- Dividend Yield
- LRHC N/A
- KTTA N/A
- EPS Growth
- LRHC N/A
- KTTA N/A
- EPS
- LRHC N/A
- KTTA N/A
- Revenue
- LRHC $78,037,079.00
- KTTA N/A
- Revenue This Year
- LRHC N/A
- KTTA N/A
- Revenue Next Year
- LRHC N/A
- KTTA N/A
- P/E Ratio
- LRHC N/A
- KTTA N/A
- Revenue Growth
- LRHC 54.92
- KTTA N/A
- 52 Week Low
- LRHC $4.33
- KTTA $0.65
- 52 Week High
- LRHC $142.40
- KTTA $7.50
- Technical
- Relative Strength Index (RSI)
- LRHC 58.69
- KTTA 46.13
- Support Level
- LRHC $6.86
- KTTA $0.74
- Resistance Level
- LRHC $9.72
- KTTA $0.81
- Average True Range (ATR)
- LRHC 0.81
- KTTA 0.06
- MACD
- LRHC 0.21
- KTTA -0.01
- Stochastic Oscillator
- LRHC 56.26
- KTTA 18.63
About LRHC La Rosa Holdings Corp.
La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).